Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Københavns Universitets forskningsportal Forside
Hjælp og OSS
Dansk
English
Forside
Profiler
Publikation
Forskningsenheder
Presse/medier
Aktiviteter
Priser
???studenttheses???
Forskningsdatasæt
Søg efter ekspertise, navn eller tilknytning
Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists
Rasmus M Christensen,
Christian R Juhl
,
Signe S Torekov
Biomedicinsk Institut
Torekov Group
Endocrinology and Metabolism
5
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Medicin og biovidenskab
Glucagon-Like Peptide-1 Receptor
66%
Liraglutide
47%
semaglutide
44%
Risk Assessment
42%
Weight Loss
42%
Obesity
35%
Anti-Obesity Agents
24%
Pharmaceutical Preparations
21%
Life Style
20%
Safety
14%
Comorbidity
13%
Body Weight
12%
Placebos
11%
Marketing
9%
Gastrointestinal Diseases
9%
Half-Life
7%
Homeostasis
6%
Hormones
5%
Diet
5%
Drug Therapy
5%
Therapeutics
2%
Kemiske forbindelser
Glucagon-Like Peptide-1 Receptor Agonist
100%
Liraglutide
65%
Weight
27%
Drug
26%
Antiobesity
25%
Safety
21%
Gastrointestinal Hormone
14%
Once Daily
14%
Reaction Half Life
8%
Disorder
7%
Energy
3%